GPT and metabolic dysfunction-associated steatohepatitis: Biopsy-proven NASH/overweight/obese/diabetic/ALT ≥ 30 U/L in patients with BMI ≤ 40 kg/m2 and ≥8% liver fat content on MRI-PDFF. (142)